Article
The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucose.
Clinical biochemistry - 1 Mar 2026
de Luis Daniel, Izaola Olatz, Primo David
Abstract excerpt
BACKGROUND & AIMS: A significant association has been confirmed between the rs10811661 polymorphism in the CDKN2 gene, and increased susceptibility to type 2 diabetes. The present study aimed to investigate the association of the rs10811661 polymorphism with metabolic syndrome (MS) in individuals with obesity and impaired fasting glucose (IFG). METHODS: This research was conducted on 110 individuals diagnosed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.